165 related articles for article (PubMed ID: 32958438)
1. Alcohol-Mediated Renal Sympathetic Neurolysis for the Treatment of Hypertension: The Peregrine™ Infusion Catheter.
Bertog S; Sharma A; Mahfoud F; Pathak A; Schmieder RE; Sievert K; Papademetriou V; Weber MA; Haratani N; Lobo MD; Saxena M; Kandzari DE; Fischell TA; Sievert H
Cardiovasc Revasc Med; 2021 Mar; 24():77-86. PubMed ID: 32958438
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter Alcohol-Mediated Perivascular Renal Denervation With the Peregrine System: First-in-Human Experience.
Fischell TA; Ebner A; Gallo S; Ikeno F; Minarsch L; Vega F; Haratani N; Ghazarossian VE
JACC Cardiovasc Interv; 2016 Mar; 9(6):589-98. PubMed ID: 27013159
[TBL] [Abstract][Full Text] [Related]
3. Randomised, blinded and controlled comparative study of chemical and radiofrequency-based renal denervation in a porcine model.
Bertog S; Fischel TA; Vega F; Ghazarossian V; Pathak A; Vaskelyte L; Kent D; Sievert H; Ladich E; Yahagi K; Virmani R
EuroIntervention; 2017 Feb; 12(15):e1898-e1906. PubMed ID: 27890862
[TBL] [Abstract][Full Text] [Related]
4. Peregrine system infusion catheter for neurolytic renal denervation in hypertension: an overview of its safety and efficacy.
Janas A; Wojakowski W
Expert Rev Med Devices; 2023 Mar; 20(3):179-186. PubMed ID: 36846949
[TBL] [Abstract][Full Text] [Related]
5. Alcohol-Mediated Renal Denervation Using the Peregrine System Infusion Catheter for Treatment of Hypertension.
Mahfoud F; Renkin J; Sievert H; Bertog S; Ewen S; Böhm M; Lengelé JP; Wojakowski W; Schmieder R; van der Giet M; Parise H; Haratani N; Pathak A; Persu A
JACC Cardiovasc Interv; 2020 Feb; 13(4):471-484. PubMed ID: 32081241
[TBL] [Abstract][Full Text] [Related]
6. Next generation renal denervation: chemical "perivascular" renal denervation with alcohol using a novel drug infusion catheter.
Fischell TA; Fischell DR; Ghazarossian VE; Vega F; Ebner A
Cardiovasc Revasc Med; 2015 Jun; 16(4):221-7. PubMed ID: 25979565
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of renal denervation for the management of arterial hypertension: A systematic review and meta-analysis of randomized, sham-controlled, catheter-based trials.
Stavropoulos K; Patoulias D; Imprialos K; Doumas M; Katsimardou A; Dimitriadis K; Tsioufis C; Papademetriou V
J Clin Hypertens (Greenwich); 2020 Apr; 22(4):572-584. PubMed ID: 32049436
[TBL] [Abstract][Full Text] [Related]
8. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
Worthley SG; Wilkins GT; Webster MW; Montarello JK; Delacroix S; Whitbourn RJ; Warren RJ
Atherosclerosis; 2017 Jul; 262():94-100. PubMed ID: 28531827
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension.
Mahfoud F; Sievert H; Bertog S; Lauder L; Ewen S; Lengelé JP; Wojakowski W; Schmieder R; van der Giet M; Weber MA; Kandzari DE; Parise H; Fischell TA; Pathak A; Persu A
Circ Cardiovasc Interv; 2021 Sep; 14(9):e010075. PubMed ID: 34470501
[TBL] [Abstract][Full Text] [Related]
10. Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension.
Ahmed H; Neuzil P; Skoda J; Petru J; Sediva L; Schejbalova M; Reddy VY
JACC Cardiovasc Interv; 2012 Jul; 5(7):758-65. PubMed ID: 22814781
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter non-contact microwave ablation may enable circumferential renal artery denervation while sparing the vessel intima and media.
Qian PC; Barry MA; Al-Raisi S; Kovoor P; Pouliopoulos J; Nalliah CJ; Bhaskaran A; Chik W; Kurup R; James V; Varikatt W; McEwan A; Thiagalingam A; Thomas SP
EuroIntervention; 2017 Feb; 12(15):e1907-e1915. PubMed ID: 27916745
[TBL] [Abstract][Full Text] [Related]
12. The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension.
Weber MA; Kirtane AJ; Weir MR; Radhakrishnan J; Das T; Berk M; Mendelsohn F; Bouchard A; Larrain G; Haase M; Diaz-Cartelle J; Leon MB
JACC Cardiovasc Interv; 2020 Feb; 13(4):461-470. PubMed ID: 32081240
[TBL] [Abstract][Full Text] [Related]
13. Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications.
Mahfoud F; Weber M; Schmieder RE; Lobo MD; Blankestijn PJ; Persu A; Fischell TA; Parise H; Pathak A; Kandzari DE
Am Heart J; 2021 Sep; 239():90-99. PubMed ID: 34052211
[TBL] [Abstract][Full Text] [Related]
14. Radio frequency-based renal denervation: a story of simplicity?
Götzinger F; Kunz M; Lauder L; Mahfoud F; Böhm M
Future Cardiol; 2023 Jul; 19(9):431-440. PubMed ID: 37791469
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure lowering with alcohol-mediated renal denervation using the Peregrine infusion Catheter is independent of injection site location.
Mahfoud F; Bertog S; Lauder L; Böhm M; Schmid A; Wojakowski W; Parise H; Fischell TA; Kandzari DE; Pathak A; Persu A; Sievert H
Catheter Cardiovasc Interv; 2021 Nov; 98(6):E832-E838. PubMed ID: 34472656
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of catheter-based radiofrequency renal denervation in stented renal arteries.
Mahfoud F; Tunev S; Ruwart J; Schulz-Jander D; Cremers B; Linz D; Zeller T; Bhatt DL; Rocha-Singh K; Böhm M; Melder RJ
Circ Cardiovasc Interv; 2014 Dec; 7(6):813-20. PubMed ID: 25336466
[TBL] [Abstract][Full Text] [Related]
17. Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence.
Weber MA; Mahfoud F; Schmieder RE; Kandzari DE; Tsioufis KP; Townsend RR; Kario K; Böhm M; Sharp ASP; Davies JE; Osborn JW; Fink GD; Euler DE; Cohen DL; Schlaich MP; Esler MD
JACC Cardiovasc Interv; 2019 Jun; 12(12):1095-1105. PubMed ID: 31221299
[TBL] [Abstract][Full Text] [Related]
18. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
Fengler K; Ewen S; Höllriegel R; Rommel KP; Kulenthiran S; Lauder L; Cremers B; Schuler G; Linke A; Böhm M; Mahfoud F; Lurz P
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862930
[TBL] [Abstract][Full Text] [Related]
19. Renal sympathetic denervation in a previously stented renal artery.
Berra E; Rabbia F; Rossato D; Covella M; Totaro S; Chiara F; Di Monaco S; Veglio F
J Clin Hypertens (Greenwich); 2014 Mar; 16(3):238-9. PubMed ID: 24387740
[No Abstract] [Full Text] [Related]
20. Catheter-based renal sympathetic denervation: chronic preclinical evidence for renal artery safety.
Rippy MK; Zarins D; Barman NC; Wu A; Duncan KL; Zarins CK
Clin Res Cardiol; 2011 Dec; 100(12):1095-101. PubMed ID: 21796327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
